CTOs on the Move

Worldwide Clinical Research

www.wwcr-cro.com

 
Worldwide Clinical Research is a Overland Park, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.wwcr-cro.com
  • 10955 Lowell Ave Ste 1010
    Overland Park, KS USA 66210
  • Phone: 913.681.3078

Executives

Name Title Contact Details

Similar Companies

Bp Solvay Polyethylene

Bp Solvay Polyethylene is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Evara Health

Family medicine, primary care, and dental service provider for the underserved and uninsured communities of Pinellas County.

NovaDel Pharma

NovaDel Pharma is a Flemington, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

APT Pharmaceuticals

APT Pharmaceuticals, Inc is a Burlingame, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Akcea Therapeutics

Akcea Therapeutics is a development and commercialization company focused on helping patients with serious diseases. Our priority is to drive clinical program execution, understand patient and physician needs, prepare the market, create market access, and commercialize our products on a global basis. We are driven by knowing that patients depend on us. An affiliate of Ionis Pharmaceuticals and based in Kendall Square, Cambridge, Massachusetts, Akcea was founded with a robust portfolio of development-stage drugs covering multiple targets and disease states using advanced antisense therapeutics. Akcea is derived from the Greek word for value and worth. Something that has akcea (αξία) is not common, but precious and rare. Our name supports the value we are creating for physicians, patients and their families, and other key stakeholders as we seek to commercialize a robust portfolio of development-stage, advanced, antisense therapies for serious cardiometabolic lipid disorders. Our immediate focus is to drive our clinical programs forward through development to commercialization while building on the Isis standards of excellence.